Abstract
Prolonged survival in preclinical renal xenotransplantation demonstrates that early antibody mediated rejection (AMR) can be overcome. It is now critical to evaluate and understand the pathobiology of late graft failure and devise new means to improve post xenograft outcomes. In renal allotransplantation the most common cause of late renal graft failure is transplant glomerulopathy—largely due to anti-donor MHC antibodies, particularly anti-HLA DQ antibodies. We evaluated the pig renal xenograft pathology of four long-surviving (>300 days) rhesus monkeys. We also evaluated the terminal serum for the presence of anti-SLA class I and specifically anti-SLA DQ antibodies. All four recipients had transplant glomerulopathy and expressed anti-SLA DQ antibodies. In one recipient tested for anti-SLA I antibodies, the recipient had antibodies specifically reacting with two of three SLA I alleles tested. These results suggest that similar to allotransplantation, anti-MHC antibodies, particularly anti-SLA DQ, may be a barrier to improved long-term xenograft outcomes.
Original language | English (US) |
---|---|
Article number | e12862 |
Journal | Xenotransplantation |
Volume | 31 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Authors. Xenotransplantation published by John Wiley & Sons Ltd.
Keywords
- SLA-DQ
- anti-MHC antibodies
- major histocompatibility complex
- swine leukocyte antigen
- transplant glomerulopathy
- xenoantibodies
PubMed: MeSH publication types
- Journal Article